Testosterone Tx Offers Little Help for Ejaculatory Dysfunction

This article originally appeared here.
Share this content:
Testosterone Tx Offers Little Help for Ejaculatory Dysfunction
Testosterone Tx Offers Little Help for Ejaculatory Dysfunction

FRIDAY, July 10, 2015 (HealthDay News) -- Testosterone supplements don't improve ejaculatory function in men with low testosterone, according to research published online July 9 in the Journal of Clinical Endocrinology & Metabolism.

For the trial, Darius Paduch, M.D., Ph.D., of NewYork-Presbyterian Hospital/Weill Cornell Medical Center in New York City, and colleagues included 66 men, aged 26 and older, with low testosterone levels and a history of ejaculatory dysfunction. The men were randomly selected to receive either a 2 percent testosterone solution applied to the skin, or a placebo.

The researchers found that after 16 weeks the men who received the testosterone therapy showed little improvement in ejaculatory function compared to those in the placebo group.

"This is the first clinical trial examining the treatment of a very common but poorly understood condition that affects men's physical health as well as their interpersonal relationships," Paduch said in a journal news release. He added that "although the participants in this study did not experience any significant improvement in ejaculatory function, we hope our work will spur the development of additional clinical trials to find treatments for this condition."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths